Abstract:Most gastric cancers arise in the setting of chronic inflammation which alters gland organization, such that acid-pumping parietal cells are lost, and remaining cells undergo metaplastic change in differentiation patterns. From a basic science perspective, recent progress has been made in understanding how atrophy and initial pyloric metaplasia occur. However, pathologists and cancer biologists have long been focused on the development of intestinal metaplasia patterns in this setting. Arguably, much less progress has been made in understanding the mechanisms that lead to the intestinalization seen in chronic atrophic gastritis and pyloric metaplasia. One plausible explanation for this disparity lies in the notable absence of reliable and reproducible small animal models within the field, which would facilitate the investigation of the mechanisms underlying the development of gastric intestinal metaplasia (GIM). This review offers an in-depth exploration of the current state of research in GIM, shedding light on its pivotal role in tumorigenesis. We delve into the histological subtypes of GIM and explore their respective associations with tumor formation. We present the current repertoire of biomarkers utilized to delineate the origins and progression of GIM and provide a comprehensive survey of the available, albeit limited, mouse lines employed for modeling GIM and engage in a discussion regarding potential cell lineages that serve as the origins of GIM. Finally, we expound upon the myriad signaling pathways recognized for their activity in GIM and posit on their potential overlap and interactions that contribute to the ultimate manifestation of the disease phenotype. Through our exhaustive review of the progression from gastric disease to GIM, we aim to establish the groundwork for future research endeavors dedicated to elucidating the etiology of GIM and developing strategies for its prevention and treatment, considering its potential precancerous nature.

Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review

The role of bile acid in intestinal metaplasia

Research progress on the relationship between bile reflux and intestinal metaplasia and the associated molecular mechanisms

Bile reflux and bile acids in the progression of gastric intestinal metaplasia

Gastric Microbiota in Gastric Cancer and Precancerous Stages: Mechanisms of Carcinogenesis and Clinical Value

Role of the Gastric Microbiome in Gastric Cancer: from Carcinogenesis to Treatment

Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori)

Research progress of regulatory molecules involved in intestinal metaplasia of gastric mucosa

TGR5-HNF4α axis contributes to bile acid-induced gastric intestinal metaplasia markers expression

Gastric intestinal metaplasia: progress and remaining challenges

HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia

HDAC6/FOXP3/HNF4 axis promotes bile acids induced gastric intestinal metaplasia

HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia

Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface

MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia

Essential role of ALKBH5-mediated RNA demethylation modification in bile acid-induced gastric intestinal metaplasia

Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach

Bile acids increase intestinal markers via FXR/SNAI2/miR-1 axis in the stomach

Critical Roles of Bile Acids in Regulating Intestinal Mucosal Immune Responses

Bile Acids Promote Gastric Intestinal Metaplasia By Upregulating Cdx2 And Muc2 Expression Via The Fxr/Nf-B Signalling Pathway

From intestinal metaplasia to gastric cancer: Witnessing the rise of evil over time and space.